CHAPTER 1. Industry Overview of Therapeutic Plasma Exchange Market
1.1. Definition and Scope
1.1.1. Definition of Therapeutic Plasma Exchange
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Therapeutic Plasma Exchange Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Therapeutic Plasma Exchange Market By Disease Indication
1.2.3. Therapeutic Plasma Exchange Market By End-User
1.2.4. Therapeutic Plasma Exchange Market By Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Sources
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Therapeutic Plasma Exchange Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Therapeutic Plasma Exchange Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2021
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Therapeutic Plasma Exchange Market By Disease Indication
4.1. Introduction
4.2. Therapeutic Plasma Exchange Market Revenue (USD Billion) By Disease Indication
4.2.1. Therapeutic Plasma Exchange Market Revenue (USD Billion) and Forecast By Disease Indication, 2018-2030
4.2.2. Renal Disorders
4.2.2.1. Renal Disorders Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.3. Neurological Disorders
4.2.3.1. Neurological Disorders Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.4. Hematology Disorders
4.2.4.1. Hematology Disorders Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.5. Metabolic Disorders
4.2.5.1. Metabolic Disorders Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 5. Therapeutic Plasma Exchange Market By End-User
5.1. Introduction
5.2. Therapeutic Plasma Exchange Market Revenue (USD Billion) By End-User
5.2.1. Therapeutic Plasma Exchange Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
5.2.2. Hospitals
5.2.2.1. Hospitals Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.3. Specialty Clinics
5.2.3.1. Specialty Clinics Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 6. North America Therapeutic Plasma Exchange Market By Country
6.1. North America Therapeutic Plasma Exchange Market Overview
6.2. U.S.
6.2.1. U.S. Therapeutic Plasma Exchange Market Revenue (USD Billion) and Forecast By Disease Indication, 2018-2030
6.2.2. U.S. Therapeutic Plasma Exchange Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
6.3. Canada
6.3.1. Canada Therapeutic Plasma Exchange Market Revenue (USD Billion) and Forecast By Disease Indication, 2018-2030
6.3.2. Canada Therapeutic Plasma Exchange Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
6.4. North America PEST Analysis
CHAPTER 7. Europe Therapeutic Plasma Exchange Market By Country
7.1. Europe Therapeutic Plasma Exchange Market Overview
7.2. U.K.
7.2.1. U.K. Therapeutic Plasma Exchange Market Revenue (USD Billion) and Forecast By Disease Indication, 2018-2030
7.2.2. U.K. Therapeutic Plasma Exchange Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
7.3. Germany
7.3.1. Germany Therapeutic Plasma Exchange Market Revenue (USD Billion) and Forecast By Disease Indication, 2018-2030
7.3.2. Germany Therapeutic Plasma Exchange Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
7.4. France
7.4.1. France Therapeutic Plasma Exchange Market Revenue (USD Billion) and Forecast By Disease Indication, 2018-2030
7.4.2. France Therapeutic Plasma Exchange Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
7.5. Spain
7.5.1. Spain Therapeutic Plasma Exchange Market Revenue (USD Billion) and Forecast By Disease Indication, 2018-2030
7.5.2. Spain Therapeutic Plasma Exchange Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
7.6. Rest of Europe
7.6.1. Rest of Europe Therapeutic Plasma Exchange Market Revenue (USD Billion) and Forecast By Disease Indication, 2018-2030
7.6.2. Rest of Europe Therapeutic Plasma Exchange Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
7.7. Europe PEST Analysis
CHAPTER 8. Asia Pacific Therapeutic Plasma Exchange Market By Country
8.1. Asia Pacific Therapeutic Plasma Exchange Market Overview
8.2. China
8.2.1. China Therapeutic Plasma Exchange Market Revenue (USD Billion) and Forecast By Disease Indication, 2018-2030
8.2.2. China Therapeutic Plasma Exchange Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
8.3. Japan
8.3.1. Japan Therapeutic Plasma Exchange Market Revenue (USD Billion) and Forecast By Disease Indication, 2018-2030
8.3.2. Japan Therapeutic Plasma Exchange Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
8.4. India
8.4.1. India Therapeutic Plasma Exchange Market Revenue (USD Billion) and Forecast By Disease Indication, 2018-2030
8.4.2. India Therapeutic Plasma Exchange Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
8.5. Australia
8.5.1. Australia Therapeutic Plasma Exchange Market Revenue (USD Billion) and Forecast By Disease Indication, 2018-2030
8.5.2. Australia Therapeutic Plasma Exchange Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
8.6. South Korea
8.6.1. South Korea Therapeutic Plasma Exchange Market Revenue (USD Billion) and Forecast By Disease Indication, 2018-2030
8.6.2. South Korea Therapeutic Plasma Exchange Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
8.7. Rest of Asia-Pacific
8.7.1. Rest of Asia-Pacific Therapeutic Plasma Exchange Market Revenue (USD Billion) and Forecast By Disease Indication, 2018-2030
8.7.2. Rest of Asia-Pacific Therapeutic Plasma Exchange Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
8.8. Asia Pacific PEST Analysis
CHAPTER 9. Latin America Therapeutic Plasma Exchange Market By Country
9.1. Latin America Therapeutic Plasma Exchange Market Overview
9.2. Brazil
9.2.1. Brazil Therapeutic Plasma Exchange Market Revenue (USD Billion) and Forecast By Disease Indication, 2018-2030
9.2.2. Brazil Therapeutic Plasma Exchange Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
9.3. Mexico
9.3.1. Mexico Therapeutic Plasma Exchange Market Revenue (USD Billion) and Forecast By Disease Indication, 2018-2030
9.3.2. Mexico Therapeutic Plasma Exchange Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
9.4. Rest of Latin America
9.4.1. Rest of Latin America Therapeutic Plasma Exchange Market Revenue (USD Billion) and Forecast By Disease Indication, 2018-2030
9.4.2. Rest of Latin America Therapeutic Plasma Exchange Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
9.5. Latin America PEST Analysis
CHAPTER 10. Middle East & Africa Therapeutic Plasma Exchange Market By Country
10.1. Middle East & Africa Therapeutic Plasma Exchange Market Overview
10.2. GCC
10.2.1. GCC Therapeutic Plasma Exchange Market Revenue (USD Billion) and Forecast By Disease Indication, 2018-2030
10.2.2. GCC Therapeutic Plasma Exchange Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
10.3. South Africa
10.3.1. South Africa Therapeutic Plasma Exchange Market Revenue (USD Billion) and Forecast By Disease Indication, 2018-2030
10.3.2. South Africa Therapeutic Plasma Exchange Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
10.4. Rest of Middle East & Africa
10.4.1. Rest of Middle East & Africa Therapeutic Plasma Exchange Market Revenue (USD Billion) and Forecast By Disease Indication, 2018-2030
10.4.2. Rest of Middle East & Africa Therapeutic Plasma Exchange Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
10.5. Middle East & Africa PEST Analysis
CHAPTER 11. Player Analysis Of Therapeutic Plasma Exchange Market
11.1. Therapeutic Plasma Exchange Company Share Analysis
11.2. Competition Matrix
11.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
11.2.2. Product Launches and Product Enhancements
11.2.3. Mergers And Acquisition In Global Therapeutic Plasma Exchange market
11.2.4. Partnership, Joint Ventures and Strategic Alliances/Sales Agreements
CHAPTER 12. Company Profile
12.1. Asahi Kasei Corporation
12.1.1. Company Snapshot
12.1.2. Business Overview
12.1.3. Financial Overview
12.1.3.1. Revenue (USD Billion), 2021
12.1.3.2. Asahi Kasei Corporation 2021 Therapeutic Plasma Exchange Business Regional Distribution
12.1.4. Product/ Service and Specification
12.1.5. Recent Developments & Business Strategy
12.1.6. Manufacturing Plant Footprint Analysis
12.2. Baxter International, Inc.
12.3. Terumo Corporation
12.4. B. Braun Melsungen AG
12.5. Fresenius Kabi AG
12.6. Kawasumi Laboratories, Inc.
12.7. Haemonetics Corporation
12.8. Cerus Corporation
12.9. Hemacare Corporation
12.10. Medica S.p.A.
